EarlySight has achieved CE certification under the European Union’s Medical Device Regulation for Cellularis® Discovery

EarlySight is excited to highlight today the successful completion of the CE conformity process under MDR for Cellularis® Discovery.
Cellularis Discovery is a revolutionary ophthalmic camera for investigating the anatomy and the pathological processes of the eye posterior segment. It provides widefield and adaptive optics high-resolution images of the retinal pigment epithelium, the photoreceptors, and the nerve fiber layers.
Thanks to its patented technology using transscleral flood illumination, EarlySight aims to build a thriving community of early adopters, including prominent doctors, esteemed professionals from the pharmaceutical industry and academic research institutions.

Recent Posts